A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6354
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity ; volume:13 ; number:2 ; day:8 ; month:4 ; year:2011 ; pages:1-12 ; date:4.2011
Arthritis Research & Therapy ; 13, Heft 2 (8.4.2011), 1-12, 4.2011
- Creator
-
Feng, Yang
- Contributor
-
Shen, Jiayin
Streaker, Emily D.
Lockwood, Michael
Zhu, Zhongyu
Low, Philip S.
Dimitrov, Dimiter S.
SpringerLink (Online service)
- DOI
-
10.1186/ar3312
- URN
-
urn:nbn:de:1111-2016050318491
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Feng, Yang
- Shen, Jiayin
- Streaker, Emily D.
- Lockwood, Michael
- Zhu, Zhongyu
- Low, Philip S.
- Dimitrov, Dimiter S.
- SpringerLink (Online service)
Other Objects (12)
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
Monoclonal antibody therapy
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity
Mechanisms of resistance to antibody-dependent cell-mediated cytotoxicity by human immunodeficiency virus
Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies
The role of antibody-dependent cellular cytotoxicity for IgG1 monoclonal antibody therapy of metastatic colorectal cancer
Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1
Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison with an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based Assay
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice
Monoclonal antibody applications in travel medicine
Novel anti-CD38 humanized mAb SG003 possessed enhanced cytotoxicity in lymphoma than Daratumumab via antibody-dependent cell-mediated cytotoxicity
Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
Monoclonal antibody therapy
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity
Mechanisms of resistance to antibody-dependent cell-mediated cytotoxicity by human immunodeficiency virus
Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies
The role of antibody-dependent cellular cytotoxicity for IgG1 monoclonal antibody therapy of metastatic colorectal cancer
Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1
Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison with an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based Assay
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice
Monoclonal antibody applications in travel medicine
Novel anti-CD38 humanized mAb SG003 possessed enhanced cytotoxicity in lymphoma than Daratumumab via antibody-dependent cell-mediated cytotoxicity
Population pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
Monoclonal antibody therapy
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicity
Mechanisms of resistance to antibody-dependent cell-mediated cytotoxicity by human immunodeficiency virus
Anticancer activity and antibody-dependent cell-mediated cytotoxicity of novel anti-nucleolin antibodies
The role of antibody-dependent cellular cytotoxicity for IgG1 monoclonal antibody therapy of metastatic colorectal cancer
Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1
Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison with an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based Assay
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice
Monoclonal antibody applications in travel medicine
Novel anti-CD38 humanized mAb SG003 possessed enhanced cytotoxicity in lymphoma than Daratumumab via antibody-dependent cell-mediated cytotoxicity